What key experiences or clinical gaps motivated your focus on advancing prostate cancer diagnostics, particularly MRI-led ...

Milestone reflects accelerating adoption of innovative, non-surgical treatment options for uterine conditionsTORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ...

Francis Medical, Inc., a privately-held medical device company, announced the first commercial procedure using the Vanquish Water Vapor Ablation System at Pinnacle Surgery Center in Austin, Texas, by ...

Down almost 70% from all-time highs, Profound Medical is an undervalued growth stock that offers significant upside potential ...

For prostate biopsy planning, multiparametric MRI has relatively low specificity particularly for PI-RADS 3 and PI-RADS 4 ...

A surgeon at St. Clair Hospital in Mt. Lebanon recently performed the first HIFU procedure for prostate cancer at St. Clair using advanced new ultrasound technology. This makes St. Clair the first ...

Lake Street Life-Sciences Invitational: Profound is scheduled to participate in a series of one-on-one meetings February 4 th- 5 th in Scottsdale, AZ. BTIG 13th Annual MedTech, Digital Health, Life ...

Mercy Medical Center is offering a new, noninvasive treatment option for men with localized prostate cancer using ...

CEDAR RAPIDS, Iowa — Mercy Medical Center has introduced a new non-invasive treatment for men with localized prostate cancer ...

In a randomized trial of men with a single suspicious lesion on MRI, targeted perilesional biopsy matched standard targeted and systematic biopsy for detecting clinically significant prostate cancer - ...

New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.

Dr Veeru Kasivisvanathan (UCL Division of Surgery & Interventional Science) has been awarded the prestigious Society of ...